• Eur. J. Cancer · Aug 2020

    Review

    A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries.

    • Yazid Belkacemi, Noemie Grellier, Sahar Ghith, Kamel Debbi, Gabriele Coraggio, Adda Bounedjar, Redouane Samlali, Pauletta G Tsoutsou, Mahmut Ozsahin, Marie-Pierre Chauvet, Sedat Turkan, Hamouda Boussen, Abraham Kuten, Dusanka Tesanovic, Hassan Errihani, Farouk Benna, Kamel Bouzid, Ahmed Idbaih, Karima Mokhtari, Lazar Popovic, Jean-Philippe Spano, Jean-Pierre Lotz, Aziz Cherif, Hahn To, Vladimir Kovcin, Oliver Arsovski, Semir Beslija, Radan Dzodic, Ivan Markovic, Suzana Vasovic, Liljana Stamatovic, Davorin Radosavljevic, Sinisa Radulovic, Damir Vrbanec, Souha Sahraoui, Nino Vasev, Igor Stojkovski, Milan Risteski, Salvador Villà Freixa, Marco Krengli, Nina Radosevic, Giorgio Mustacchi, Mladen Filipovic, Khaldoun Kerrou, Alphonse G Taghian, Vladimir Todorovic, Fady Geara, and Joseph Gligorov.
    • Department of Radiation Oncology and Henri Mondor Breast Center, APHP, INSERM Unit 955 Team 21, University of Paris-Est Creteil (UPEC), France. Electronic address: yazid.belkacemi@aphp.fr.
    • Eur. J. Cancer. 2020 Aug 1; 135: 130-146.

    AbstractCoronavirus disease 2019 (COVID-19) is an infectious disease caused by a new virus that has never been identified in humans before. COVID-19 caused at the time of writing of this article, 2.5 million cases of infections in 193 countries with 165,000 deaths, including two-third in Europe. In this context, Oncology Departments of the affected countries had to adapt quickly their health system care and establish new organizations and priorities. Thus, numerous recommendations and therapeutic options have been reported to optimize therapy delivery to patients with chronic disease and cancer. Obviously, while these cancer care recommendations are immediately applicable in Europe, they may not be applicable in certain emerging and low- and middle-income countries (LMICs). In this review, we aimed to summarize these international guidelines in accordance with cancer types, making a synthesis for daily practice to protect patients, staff and tailor anti-cancer therapy delivery taking into account patients/tumour criteria and tools availability. Thus, we will discuss their applicability in the LMICs with different organizations, limited means and different constraints.Copyright © 2020 Elsevier Ltd. All rights reserved.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…